These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 158612

  • 1. The beige mutation in the mouse. II. Selectivity of the natural killer (NK) cell defect.
    Roder JC, Lohmann-Matthes ML, Domzig W, Wigzell H.
    J Immunol; 1979 Nov; 123(5):2174-81. PubMed ID: 158612
    [No Abstract] [Full Text] [Related]

  • 2. The beige mutation in the mouse. I. A stem cell predetermined impairment in natural killer cell function.
    Roder JC.
    J Immunol; 1979 Nov; 123(5):2168-73. PubMed ID: 489978
    [Abstract] [Full Text] [Related]

  • 3. Immunological studies of NK cell-deficient beige mice. II. Analysis of T-lymphocyte functions in beige mice.
    Baca ME, Mowat AM, Parrott DM.
    Immunology; 1989 Jan; 66(1):131-7. PubMed ID: 15493275
    [Abstract] [Full Text] [Related]

  • 4. Immunological studies of NK cell-deficient beige mice. I. Defective ability of beige lymphocytes to mediate local and systemic graft-versus-host reactions.
    Baca ME, Mowat AM.
    Immunology; 1989 Jan; 66(1):125-30. PubMed ID: 15493274
    [Abstract] [Full Text] [Related]

  • 5. Cytotoxic Thy 1,2-positive blasts with NK-like target selectivity in murine mixed lymphocyte cultures.
    Kärre K, Seeley JK.
    J Immunol; 1979 Oct; 123(4):1511-8. PubMed ID: 158052
    [No Abstract] [Full Text] [Related]

  • 6. Lack of specificity for viral and H-2 antigens by anomalous T killer cells generated in murine leukocyte cultures.
    Shain B, Holt CA, Lilly F.
    J Immunol; 1982 Aug; 129(2):722-9. PubMed ID: 6177779
    [Abstract] [Full Text] [Related]

  • 7. Genetic control of in vitro NK-activity and in vivo resistance to tumors.
    Kärre K, Klein GO, Kiessling R, Klein G.
    Tokai J Exp Clin Med; 1983 Dec; 8(5-6):429-48. PubMed ID: 6681339
    [Abstract] [Full Text] [Related]

  • 8. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F, Peri G, Villa A, Mantovani A.
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [Abstract] [Full Text] [Related]

  • 9. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
    Holmes KV, Welsh RM, Haspel MV.
    J Immunol; 1986 Feb 15; 136(4):1446-53. PubMed ID: 3003198
    [Abstract] [Full Text] [Related]

  • 10. A phenyl-beta-galactoside-specific monoclonal antibody reactive with murine and rat NK cells.
    Miller VE, Lagarde AE, Longenecker BM, Greenberg AH.
    J Immunol; 1986 Apr 15; 136(8):2968-74. PubMed ID: 2420880
    [Abstract] [Full Text] [Related]

  • 11. 5-halo-6-phenyl pyrimidinones: new molecules with cancer therapeutic potential and interferon-inducing capacity are strong inducers of murine natural killer cells.
    Lotzová E, Savary CA, Stringfellow DA.
    J Immunol; 1983 Feb 15; 130(2):965-9. PubMed ID: 6848603
    [Abstract] [Full Text] [Related]

  • 12. The selective growth of murine newborn-derived suppressor cells and their probable mode of action.
    Jadus MR, Parkman R.
    J Immunol; 1986 Feb 01; 136(3):783-92. PubMed ID: 2934478
    [Abstract] [Full Text] [Related]

  • 13. Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells.
    Andrews KJ, Ribas A, Butterfield LH, Vollmer CM, Eilber FC, Dissette VB, Nelson SD, Shintaku P, Mekhoubad S, Nakayama T, Taniguchi M, Glaspy JA, McBride WH, Economou JS.
    Cancer Res; 2000 Nov 15; 60(22):6457-64. PubMed ID: 11103813
    [Abstract] [Full Text] [Related]

  • 14. Increased natural killer cell activity in experimental American trypanosomiasis.
    Hatcher FM, Kuhn RE, Cerrone MC, Burton RC.
    J Immunol; 1981 Sep 15; 127(3):1126-30. PubMed ID: 6790614
    [Abstract] [Full Text] [Related]

  • 15. Selective defect of natural killer and killer cell activity against lymphomas in SJL mice: low responsiveness to interferon inducers.
    Kaminsky SG, Nakamura I, Cudkowicz G.
    J Immunol; 1983 Apr 15; 130(4):1980-4. PubMed ID: 6833756
    [Abstract] [Full Text] [Related]

  • 16. Natural killer (NK) cells as a responder to interleukin 2 (IL 2). I. Proliferative response and establishment of cloned cells.
    Suzuki R, Handa K, Itoh K, Kumagai K.
    J Immunol; 1983 Feb 15; 130(2):981-7. PubMed ID: 6600260
    [Abstract] [Full Text] [Related]

  • 17. [Effect of a delayed type hypersensitivity reaction on the cytotoxic activity of macrophages, natural and antibody-dependent killer cells].
    Gordienko SM.
    Eksp Onkol; 1987 Feb 15; 9(1):30-4. PubMed ID: 3816657
    [Abstract] [Full Text] [Related]

  • 18. The beige mutation in the mouse selectively impairs natural killer cell function.
    Roder J, Duwe A.
    Nature; 1979 Mar 29; 278(5703):451-3. PubMed ID: 313007
    [No Abstract] [Full Text] [Related]

  • 19. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
    Kawase I, Komuta K, Hara H, Inoue T, Hosoe S, Ikeda T, Shirasaka T, Yokota S, Tanio Y, Masuno T.
    Cancer Res; 1988 Mar 01; 48(5):1173-9. PubMed ID: 3257715
    [Abstract] [Full Text] [Related]

  • 20. Evidence that lymphokine-activated killer cells and natural killer cells are distinct based on an analysis of congenitally immunodeficient mice.
    Andriole GL, Mulé JJ, Hansen CT, Linehan WM, Rosenberg SA.
    J Immunol; 1985 Nov 01; 135(5):2911-3. PubMed ID: 3876368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.